GlaxoSmithKline Plans to Launch Five Major Vaccines Over Next Five Years Worth Up to $18 Billion
Our Hometown Pharmaceutical Company!!!...
link from yahoo finance AP story
Thursday, June 30, 2005
Saturday, June 25, 2005
Friday, June 24, 2005
link from in-pharma-tech
20/06/2005 - US biotechnology company Biogen Idec has said that it plans to sell a California manufacturing plant built to produce its withdrawn multiple sclerosis drug Tysabri (natalizumab) to Genentech, reports Phil Taylor.
Maybe the plant needs to be converted to produce the other product!!!
Friday, June 17, 2005
Thursday, June 16, 2005
Friday, June 10, 2005
Tuesday, June 07, 2005
Some bold predictions on what's coming for the industry from Ernst & Young's Scott Morrison
On June 1, financial-services provider Ernst & Young released its 19th annual report on the biotechnology industry. The firm is so optimistic about biotech's future it declares that in the U.S., the sector is "coming of age."
link from business week online
hey, you didn't hear this from me...
Monday, June 06, 2005
04/06/2005 - Scientists have successfully achieved the production of a functional humanised antibody in the whites of eggs laid by a transgenic hen, opening the door to using transgenic flocks as an alternative to mammalian cell culture for the production of many protein drugs, reports Phil Taylor.
link from in-pharma tech
Maybe firms will start building a collection of facilties to house flocks of poultry...
04/06/2005 - In-PharmaTechnologist.com reports its periodic round-up of new appointments in the pharmaceutical sector, headlined this week by the appointment of a new head of manufacturing at US drugmaker Merck & Co.
Willie Deese, currently senior vice president of global procurement at Merck & Co, has been named president of the group's manufacturing division, succeeding Richard Clark who has been elected chief executive of the firm following the recently announced resignation of Raymond Gilmartin.